Prof. Sanna Toppila-Salmi

Sanna Toppila-Salmi, MD, PhD, Adj. Prof. is a Senior Consultant Otorhinolaryngologist, Department Chief Physician and Director of Helsinki Airway Research Group at the Skin and Allergy Hospital of the Helsinki University Hospital & University of Helsinki.  Her research group combines epidemiology, genomics, metabolomics and sequence analysis to identify pathobiology of NERD, Type 2 inflammation, CRSwNP, asthma and allergic diseases. Her lab works with human cohorts to identify risk factors, mechanisms, and potential therapies for these disorders using machine learning data science, sequencing omics approaches and clinical trials. Findings from her lab: birch pollen allergen immunotherapy induced a recovery of nasal epithelial microbial diversity and host transcriptome towards control; maternal smoking exposure in utero increased cumulative asthma incidence of adult offspring, who carry RUNX-1 gene variant. Funding of her lab include State funding for university-level health research and Tampere Tuberculosis Foundation. Dr. Toppila-Salmi is Associate Editor of Clinical and Translational Allergy, and Editorial Board Member and Reviewer in several Scientific Journals such as Am J Respir Crit Care Med, BMC Medical Genetics, BMJ Open, JACI and Scientific Reports. She is the secretary of ENT section of EAACI.